Article
[Molecular biology of castration-resistant prostate cancer].
Bulletin du cancer - 1 Jun 2015
Doucet Ludovic, Terrisse Safae, Gauthier Hélène, Pouessel Damien, Le Maignan Christine, Teixeira Luis, Culine Stéphane
Abstract excerpt
Castration-resistant prostate cancer was subjected to a paradigm switch from hormone resistance to androgen deprivation therapy resistance during the last decade. Indeed, new therapeutics targeting the androgen receptor showed clinical efficacy in patients with progressive disease under castration. Thus, it is a proof that the AR remains a dominant driver of oncogenesis in earlier-called hormone resistant...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
